Difference between revisions of "Changing ambient UVR and future skin cancer in London, Rome and Helsinki: melanoma skin cancer (CMM)"
Iranjon 95 (talk | contribs) (BeginingUVR) |
Iranjon 95 (talk | contribs) |
||
Line 10: | Line 10: | ||
The international mechanism for protecting the ozone layer is the “Montreal Protocol on Substances That Deplete the Ozone Layer” that came into force in 1989 and its subsequent amendments (UNEP 2006). The production of the most harmful ozone depleting substances (ODS) are now phased out worldwide. The atmospheric concentrations of these gases is anticipated to decline over the next decades (IPCC 2005). As a result stratospheric ozone is expected to increase and, subsequently, ambient UVR is anticipated to decrease. Hence, a decrease in melanoma skin cancer is expected, but other factors may play an important role as well such as the ageing of the population. | The international mechanism for protecting the ozone layer is the “Montreal Protocol on Substances That Deplete the Ozone Layer” that came into force in 1989 and its subsequent amendments (UNEP 2006). The production of the most harmful ozone depleting substances (ODS) are now phased out worldwide. The atmospheric concentrations of these gases is anticipated to decline over the next decades (IPCC 2005). As a result stratospheric ozone is expected to increase and, subsequently, ambient UVR is anticipated to decrease. Hence, a decrease in melanoma skin cancer is expected, but other factors may play an important role as well such as the ageing of the population. | ||
− | == | + | ==Scope== |
− | |||
− | + | '''Description''' | |
− | + | We explore the effects of changing exposure to ambient ultraviolet radiation (UVR) on melanoma skin cancer, accounting for the recovery of the ozone layer due to decreasing emission of ODS and future emissions of CH4 and N20 (IPCC 2005). We also account for future demographic change | |
− | + | [[File:Summary_report_fig_1_0.jpg|400]] | |
− | + | '''Scenario(s) and Type of Assessment''' | |
− | |||
− | + | Type of assessment: prognostic. | |
− | + | UVR scenarios: IPCC (2000) SRES A2 and B1: future population & emissions/concentrations of ODS, CH4 and N2O. | |
− | |||
− | + | SRES population scenarios were downscaled from the regional to the city-level. | |
− | |||
− | = | + | {|{{prettytable}} |
+ | {| style="width:35%; height:100px" | ||
+ | !'''IPCC Senario''' | ||
+ | !'''SRES-A2''' | ||
+ | !'''SRES-B1''' | ||
+ | |----- | ||
+ | | '''ODS Emission''' | ||
+ | | Decreasing trend | ||
+ | Same B1 | ||
+ | | Decreasing trend | ||
+ | same as A2 | ||
+ | |----- | ||
+ | | '''CH<sub>4</sub> Emission''' | ||
+ | | Higher Increase | ||
+ | | Lower Increase | ||
+ | |----- | ||
+ | | '''N<sub>2</sub> Emission''' | ||
+ | | Higher Increase | ||
+ | | Lower Increase | ||
+ | |----- | ||
+ | | '''Population''' | ||
+ | | Higher Growth | ||
+ | | Lower growth | ||
+ | |----- | ||
+ | | '''Age Structure''' | ||
+ | | Slower Aging | ||
+ | | Higher Aging | ||
+ | |} | ||
− | |||
− | |||
− | |||
− | + | '''Geographical and temporal scope:''' | |
− | + | Study area(s): City of Helsinki, Greater London, City of Rome | |
− | + | Populations: 5-year age groups up to 85+; males/females | |
− | + | Timeframe: 2001, 2030, 2050 | |
− | |||
− | |||
− | |||
− | |||
− | + | '''Environmental and health factors:''' | |
− | + | Source: emissions of ODS (decreasing), N2O (increasing) and CH4 (increasing) ,affecting ozone fields | |
− | + | Environmental hazard: ambient UVR (erythemal dose). | |
− | + | Other risk factor: age. | |
− | + | Health outcomes: melanoma skin cancer (CMM) incidence/mortality (rates) | |
− | |||
− | + | '''Stakeholders:''' | |
− | |||
− | |||
− | |||
− | + | {|{{prettytable}} | |
+ | ! '''Stakeholder''' | ||
+ | ! '''Interest''' | ||
+ | ! '''Role''' | ||
+ | |----- | ||
+ | | Health authorities, policy/decision makers and health promotion agencies | ||
+ | | Healthy population | ||
+ | | Issue recommendations on solar exposure | ||
+ | |----- | ||
+ | | Health care providers | ||
+ | | Disease prevention, treatment | ||
+ | | Treatment and advice particularly to groups at risk | ||
+ | |----- | ||
+ | | Societies (cancer, osteoporosis, etc) | ||
+ | | Support member interests | ||
+ | | Issue public information | ||
+ | |----- | ||
+ | | Advocacy groups | ||
+ | | Protecting vulnerable groups | ||
+ | | Reduce health impacts related to UVR. | ||
+ | |----- | ||
+ | | Researchers | ||
+ | | Research | ||
+ | | Further knowledge of UVR-related health effects | ||
− | + | |} | |
− | |||
− | + | ==Assessment methods== | |
+ | |||
+ | ==Results== | ||
+ | |||
+ | ==Appraisal== | ||
==See also== | ==See also== |
Revision as of 12:28, 17 August 2011
[[Category: ]]
This page is a assessment.
The page identifier is Op_en5333 |
---|
Moderator:iranjon_95 (see all) |
This page is a stub. You may improve it into a full page, and then a rating bar will appear here. |
Upload data
|
Add at least one category above.
Add moderator to the template above.
It is widely accepted that ambient UVR is carcinogenic (Lucas et al 2006). This assessment will focus on the impact on malignant melanoma skin cancer (CMM).
The international mechanism for protecting the ozone layer is the “Montreal Protocol on Substances That Deplete the Ozone Layer” that came into force in 1989 and its subsequent amendments (UNEP 2006). The production of the most harmful ozone depleting substances (ODS) are now phased out worldwide. The atmospheric concentrations of these gases is anticipated to decline over the next decades (IPCC 2005). As a result stratospheric ozone is expected to increase and, subsequently, ambient UVR is anticipated to decrease. Hence, a decrease in melanoma skin cancer is expected, but other factors may play an important role as well such as the ageing of the population.
Scope
Description
We explore the effects of changing exposure to ambient ultraviolet radiation (UVR) on melanoma skin cancer, accounting for the recovery of the ozone layer due to decreasing emission of ODS and future emissions of CH4 and N20 (IPCC 2005). We also account for future demographic change
Scenario(s) and Type of Assessment
Type of assessment: prognostic.
UVR scenarios: IPCC (2000) SRES A2 and B1: future population & emissions/concentrations of ODS, CH4 and N2O.
SRES population scenarios were downscaled from the regional to the city-level.
IPCC Senario | SRES-A2 | SRES-B1 |
---|---|---|
ODS Emission | Decreasing trend
Same B1 |
Decreasing trend
same as A2 |
CH4 Emission | Higher Increase | Lower Increase |
N2 Emission | Higher Increase | Lower Increase |
Population | Higher Growth | Lower growth |
Age Structure | Slower Aging | Higher Aging |
Geographical and temporal scope:
Study area(s): City of Helsinki, Greater London, City of Rome
Populations: 5-year age groups up to 85+; males/females
Timeframe: 2001, 2030, 2050
Environmental and health factors:
Source: emissions of ODS (decreasing), N2O (increasing) and CH4 (increasing) ,affecting ozone fields
Environmental hazard: ambient UVR (erythemal dose).
Other risk factor: age.
Health outcomes: melanoma skin cancer (CMM) incidence/mortality (rates)
Stakeholders:
Stakeholder | Interest | Role |
---|---|---|
Health authorities, policy/decision makers and health promotion agencies | Healthy population | Issue recommendations on solar exposure |
Health care providers | Disease prevention, treatment | Treatment and advice particularly to groups at risk |
Societies (cancer, osteoporosis, etc) | Support member interests | Issue public information |
Advocacy groups | Protecting vulnerable groups | Reduce health impacts related to UVR. |
Researchers | Research | Further knowledge of UVR-related health effects |